No Difference in Kidney Failure Risk Between Three Anti-VEGF Agents for Eye Disease
(MedPage Today) -- Of three anti-vascular endothelial growth factor (VEGF) drugs used to treat several serious eye diseases, there was no substantially different relative risk for kidney failure, a retrospective cohort study suggested.
Among over...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Study | Urology & Nephrology